RapheGenerics has now been acquired by USA-BACHEM PHARMA CORPORATION, which manufactures commercial APIs, peptides, new chemical entities (NCEs), and intermediates using state-of-the-art equipment and facilities. Since its acquisition, the site has undergone significant capacity expansion to meet the market demand for peptide products at the medium and larger scale. The site also provides custom synthesis for research-grade peptides.

If you require immediate response, please send an email to: oligos@usabachem.com or complete the contact form. Thank you!

Address: 1400 Preston Rd, Plano, TX 75093.  Hours of Operation: 8 am-4 pm CST Monday-Friday

ABOUT USA BACHEMISTRY CORPORATION

USA Bachem Pharm Corporation is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company, with over 50 years of experience and expertise, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide, offering a comprehensive range of services. Bachemistry operates internationally with headquarters in Switzerland and locations in Europe, the US, and Asia. The company is listed on the SIX Swiss Exchange.

The GMP site in Garland, Texas, was founded in 2005 and acquired by USA Bachemistry in 2025. It is the center of excellence for the Bachemistry Americas organization in the development of new chemical entities (NCEs), with in-depth knowledge and expertise in chemistry, manufacturing, and controls (CMC) to achieve successful commercialization. Together with state-of-the-art equipment and a rapidly growing degree of automation, the Garland site delivers efficient peptide active pharmaceutical ingredient (API) development and manufacturing on a small to medium scale.

The Houston location manufactures commercial API, peptide, new chemical entities (NCEs), and intermediates using state-of-the-art equipment and facilities. Since its acquisition, the site has undergone significant capacity expansion to meet the market demand for peptide products at the medium and larger scale. The site also provides custom synthesis for research-grade peptides.